Legend Biotech Corp
SEC CIK 1801198 · LEGN · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Huang Ying | Director · Chief Executive Officer | filed 2026 - 2026 |
| Sanders Corazon (Corsee) D. | Director | filed 2026 - 2026 |
| Heyman Tomas J. | Director | filed 2026 - 2026 |
| Zhang Fangliang | Director | filed 2026 - 2026 |
| Ji Darren Xiaohui | Director | filed 2026 - 2026 |
| Casey Patrick John | Director | filed 2026 - 2026 |
| Salovey Peter | Director | filed 2026 - 2026 |
| Mao Li | Director | filed 2026 - 2026 |
| Wang Ye | Director | filed 2026 - 2026 |
| Meng Robin | Director | filed 2026 - 2026 |
| Kung Gareth | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Santos Carlos E | Chief Financial Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.